RadNet Inc (NASDAQ: RDNT) is a diagnostic imaging services company that owns and operates outpatient imaging centers across the United States. Revenue is generated through fee-for-service billings to third-party payors and through capitation arrangements, with service fee revenue representing 93.8% of total service revenue and capitation arrangements 6.2% in FY2025. RadNet's centers are organized into regional networks concentrated in major population centers across nine states, competing against hospitals and other outpatient imaging operators by offering multi-modality services at a single location at fees generally below hospital rates. The company also operates a Digital Health segment, which generated $92.7 million in revenue in FY2025 against $65.7 million in FY2024, focused on AI-enabled radiology workflow products including clinical AI for mammography, lung, prostate, and ultrasound imaging, plus enterprise products such as RIS, PACS, and remote scanning solutions. RadNet carries significant debt, with total term loan carrying value of approximately $1.07 billion as of December 31, 2025, and total future contractual obligations of approximately $2.56 billion.
- Revenue model
- Fee-for-service billings to managed care and other third-party payors (93.8% of service revenue in FY2025) plus capitation arrangements (6.2% of service revenue in FY2025). Digital Health segment revenue is transactional and subscription-based, generated from AI software and enterprise imaging products sold to outpatient and hospital radiology customers.
- Products and services
- Multi-modality diagnostic imaging services including MRI, CT, PET, mammography, ultrasound, and related procedures offered at outpatient centers. Digital Health segment products include clinical AI tools for mammography, lung, prostate, and ultrasound imaging (developed through acquisitions of DeepHealth, Aidence, Quantib, Kheiron Technologies, ICAD Inc, See Mode Technologies, and CIMAR), plus enterprise products: RIS, PACS, Reporting, and a Remote Scanning Solution.
- Customers and end markets
- Patients referred by physicians for outpatient diagnostic imaging. Revenue is substantially dependent on contracted radiology groups that hold managed care contracts. Payors include managed care organizations under both fee-for-service and capitation arrangements. The Digital Health segment sells to outpatient radiology practices and hospitals.
- Value-chain role
- Outpatient diagnostic imaging services operator and radiology workflow technology provider. Sits between referring physicians and hospital systems, providing lower-cost imaging alternatives. Contracts with independent radiology groups to provide medical services at its centers under management agreements.
- Geographic exposure
- Nine U.S. states, concentrated in major population centers, as disclosed in the 10-K filed 2026-03-02.
Source: SEC 10-K, filed 2026-03-02
Industry:
Services-Medical Laboratories
Peers:
Accolade, Inc.
Cross Country Healthcare Inc
CVS Health Corp
DocGo Inc
P3 Health Partners Inc
Fulgent Genetics Inc
Hims & Hers Health Inc
InnovAge Holding Corp
National Research Corp